The global healthcare landscape has experienced a profound shift in the wake of the COVID-19 pandemic. Among the most significant transformations is the growing demand for In Vitro Diagnostics (IVD) and diagnostic distribution networks. As countries strive to strengthen their healthcare infrastructure, the IVD sector is emerging as a critical area